logo
logo

Eye Drug Maker Neurophth Snags $63M Series C Co-Led By Sequoia China

Nov 29, 2021over 3 years ago

Amount Raised

$63 Million

Round Type

series c

China

Description

Ophthalmic diseases-driven therapy specialist Neurophth Biotechnology has raised nearly 400 million yuan ($63 million) in a Series C round of financing, per a company statement on Monday

Company Information

Company

Neurophth

Location

China

About

The company has developed a pipeline of 10 products. The company received approval from the National Medical Products Administration in June this year.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech